Factors to consider in the association between soy isoflavone intake and breast cancer risk

Journal of Epidemiology

Volumn 20, Issue 2, 2010, Pages 83-89

  Nagata, Chisato ^a  

^a GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Breast cancer; Review; Soy isoflavones

Indexed keywords

ISOFLAVONE DERIVATIVE;

BREAST TUMOR; CULTURAL FACTOR; DIET; FEMALE; HUMAN; JAPAN; REVIEW; RISK FACTOR; SOYBEAN;

BREAST NEOPLASMS; CROSS-CULTURAL COMPARISON; DIET SURVEYS; FEMALE; HUMANS; ISOFLAVONES; JAPAN; RISK FACTORS; SOY FOODS;

EID: 77950616083     PISSN: 09175040     EISSN: 13499092     Source Type: Journal    
DOI: 10.2188/jea.JE20090181     Document Type: Review

References (80)

1. Martin PM, Horwitz KB, Ryan DS, McGuire WL. Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology. 1978;103:1860-7.
2. Rice S, Mason HD, Whitehead SA. Phytoestrogens and their low-dose combinations inhibit mRNA expression and activity of aromatase in human granaulosa-luteal cells. J Steroid Biochem Mol Biol. 2006;101:216-25.
3. Akiyama T, Ishida J, Nakagawa S, Ogawara H, Watanabe S, Itoh LN, et al. Genistein, a specific inhibitor of tyrosine-specific protedin kinases. J Biol Chem. 1987;262:5592-5.
4. Li Y, Upadhyay S, Bhuiyan M, Sarkar FH. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein. Oncogene. 1999;18:3166-72.
5. Fotsis T, Pepper M, Adlercreutz H, Fleischmann G, Hase T, Montesano R, et al. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc Natl Acad Sci USA. 1993;90:2690-4.
6. Watanabe S, Haba R, Terashima K, Arai Y, Miura T, Chiba H, et al. Antioxidant activity of soya hypocotyls tea in humans. Biofactors. 2000;12:227-32.
7. Verdrengh M, Jonsson IM, Holmdahl R, Tarkowski A. Genistein as an anti-inflammatory agent. Inflamm Res. 2003;52:341-6.
8. Hsieh CY, Santell RC, Haslam SZ, Helferich WG. Estrogenic effect of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res. 1998;58:3833-8.
9. Ju YH, Fultz J, Allred KF, Doerge DR, Helferich WG. Effects of dietary daidzein and its metabolite, equol, at physiologial concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athmic mice. Carcinogenesis. 2006;27:S856-63.
10. Trock BJ, Hilakivi-Clarke L, Clarke R. Meta-analysis of soy intake and breast cancer risk. J Natl Cancer Inst. 2006;98:459-71.
11. Wu AH, Yu MC, Tseng CC, Pike MC. Epidemiology of soy exposures and breast cancer risk. Br J Cancer. 2008;98:9-14.
12. Yamamoto S, Sobue T, Kobayashi M, Sasaki S, Tsugane S; Japan Public Health Center-Based Prospective Study on Cancer Cardiovascular Diseases Group. Soy, isoflavones, and breast cancer risk in Japan. J Natl Cancer Inst. 2003;95:906-13.
13. Shimizu H, Ross RK, Bernstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer. 1991;63:963-6.
14. Tsugane S, de Souza JM, Costa ML Jr, Mirra AP, Gotlieb SL, Laurenti R, et al. Cancer incidence rates among Japanese immigrants in the city of Sao Paulo, Brazil, 1969-78. Cancer Causes Control. 1990;1:189-93.
15. Curado MP, Edwards B, Shin HR, Strom H, Ferlay J, Heanue M, et al. Cancer Incidence in Five Continents, Vol. IX. IARC Scientific Publications No. 160, Lyon, IARC, 2007.
16. Katanoda K, Matsumura Y. National Nutrition Survey in Japan-its methodological transition and current findings. J Nutr Sci Vitaminol (Tokyo). 2002;48:423-32.
17. Messina M, Nagata C, Wu AH. Estimated Asian adult soy protein and isoflavone intakes. Nutr Cancer. 2006;55:1-12.
18. Kimira M, Arai Y, Shimoi K, Watanabe S. Japanese intake of flavonoids and isoflavonoids from foods. J Epidemiol. 1998;8:168-75.
19. Shimizu H. The Basic Report on Takayama Study. Gifu, Japan. Department of Public Health, Gifu University School of Medicine, 1996.
20. Nagata C, Takatsuka N, Shimizu H. Soy and fish oil intake and mortality in a Japanese community. Am J Epidemiol. 2002;156:824-31.
21. de Kleijn MJ, van der Schouw YT, Wilson PW, Adlercreutz H, Mazur W, Grobbee DE, et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study. J Nutr. 2001;131:1826-32.
22. Horn-Ross PL, Lee M, John EM, Koo J. Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control. 2000;11:299-302.
23. Keinan-Boker L, Peeters PH, Mulligan AA, Navarro C, Slimani N, Mattisson I, et al. EPIC Study Group on Soy Consumption. Soy product consumption in 10 European countries: the European Prospective Investigation into Cancer and Nutrition (EPIC) study. Public Health Nutr. 2002;5:1217-26.
24. Chun OK, Chung SJ, Song WO. Estimated dietary flavonoid intake and major food sources of U.S. adults. J Nutr. 2007;137:1244-52.
25. Takata Y, Maslkarinec G, Franke A, Nagata C, Shimizu H. A comparison of dietary habits among women in Japan and Hawaii. Public Health Nutr. 2004;7:319-26.
26. Yamamoto S, Sobue T, Sasaki S, Kobayashi M, Arai Y, Uehara M, et al. Validity and reproducibility of a self-administered food frequency questionnaire to assess isoflavone intake in a Japanese population in comparison with dietary records and blood and urine isoflavones. J Nutr. 2001;131:2741-7.
27. Arai Y, Uehara M, Sato Y, Kimira M, Eboshida A, Adlercreutz H, et al. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake. J Epidemiol. 2000;10:127-35.
28. Nagata C, Shimizu H, Takami R, Hayashi M, Takeda N, Yasuda K. Soy product intake and serum isoflavonoid and estradiol concentrations in relation to bone mineral density in postmenopausal Japanese women. Osteoporos Int. 2002;13:200-4.
29. Iwasaki M, Inoue M, Otani T, Sasazuki S, Kurahashi N, Miura T, et al. Plasma isoflavone level and subsequent risk of breast cancer among Japanese women: a nested case-control study from the Japan Public Health Center-based Prospective Study Group. J Clin Oncol. 2008;26:1677-83.
30. Nagata C, Iwasa S, Shiraki M, Ueno T, Uchiyama S, Urata K, et al. Associations among maternal soy intake, isoflavone levels in urine and blood samples, and maternal and umbilical hormone concentrations (Japan). Cancer Causes Control. 2006;17:1107-13.
31. Tsuchiya M, Miura T, Hanaoka T, Iwasaki M, Sasaki H, Tanaka T, et al. Effect of soy isoflavones on endometriosis. Interaction with estrogen receptor 2 gene polymorphism. Epidemiology. 2007;18:402-8.
32. Nagata C, Ueno T, Uchiyama S, Nagao Y, Yamamoto S, Shibuya C, et al. Dietary and lifestyle correlates of urinary excretion status of equol in Japanese women. Nutr Cancer. 2008;60:49-54.
33. Valentín-Blasini L, Sadowski MA, Walden D, Caltabiano L, Needham LL, Barr DB. Urinary phytoestrogen concentration in the U.S. population (1999-2000). J Expo Anal Environ Epidemiol. 2005;15:509-23.
34. Ward H, Chapelais G, Kuhnle GG, Luben R, Khaw KT, Bingham S. European Prospective into Cancer-Norfolk cohort. Breast cancer risk in relation to urinary and serum biomarkers of phytoestrogen exposure in the European Prospective into Cancer-Norfolk cohort study. Breast Cancer Res. 2008;10:R32-40.
35. Velentzis LS, Woodside JV, Cantwell MM, Leathem AJ, Keshtgar MR. Do phytoestrogens reduce the risk of breast cancer and breast cancer recurrence? What clinicians need to know. Eur J Cancer. 2008;44:1799-806.
36. Liggins J, Bluck LJ, Runswick S, Atkinson C, Coward WA, Bingham SA. Daidzein and genistein content of fruits and nuts. J Nutr Biochem. 2000;11:326-31.
37. Ritchie MR, Cummings JH, Morton MS, Michael Steel C, Bolton-Smith C, Riches AC. A newly constructed and validated isoflavone database for the assessment of total genistein and daidzein intake. Br J Nutr. 2006;95:204-13.
38. Kuhnle GG, Dell'Aquila C, Aspinall SM, Runswick SA, Mulligan AA, Bingham SA. Phytoestrogen content of foods of animal origin: dairy products, eggs, meat, fish, and seafoods. J Agric Food Chem. 2008;56:10099-104.
39. Coward L, Barnes NC, Setchell KD, Barnes S. Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets. J Agric Food Chem. 1993;41:1961-7.
40. Watanabe S, Yamaguchi M, Sobue T, Takahashi T, Miura T, Arai Y, et al. Pharmacokinetics of soybean isoflavones in plasma, urine and feces of men after ingestion of 60 g baked soybean powder (kinako). J Nutr. 1998;128:1710-5.
41. Nielsen IL, Williamson G. Review of the factors affecting bioavailability of soy isoflavones in humans. Nutr Cancer. 2007;57:1-10.
42. Gardner CD, Chatterjee LM, Franke AA. Effects of isoflavones vs. soy foods on blood concentrations of genistein and daidzein in adults. J Nutr Biochem. 2009;20:227-34.
43. Setchell KD, Brown NM, Lydeking-Olsen E. The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones. J Nutr. 2002;132:3577-84.
44. Ueno T, Uchiyama S, Kikuchi N. The role of intestinal bacteria on biological effects of soy isoflavones in humans [abstract]. J Nutr. 2002;132:3540S.
45. Atkinson C, Frankenfeld CL, Lampe JW. Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health. Exp Biol Med (Maywood). 2005;230:155-70.
46. Morito K, Aomori T, Hirose T, Kinjo J, Hasegawa J, Ogawa S, et al. Interaction of phytoestrogens with estrogen receptor alphaand beta. Biol Pharm Bull. 2001;24:351-6.
47. Mitchell JH, Gardner PT, McPhail DB, Morrice PC, Collins AR, Duthie GG. Antioxidant efficacy of phytoestrogens in chemical and biological model systems. Arch Biochem Biophys. 1998;360:142-8.
48. Wu J, Oka J, Higuchi M, Tabata I, Toda T, Fujioka M, et al. Cooperative effects of isoflavones and exercise on bone and lipid metabolism in postmenopausal Japanese women: a randomized placebo-controlled trial. Metabolism. 2006;55:423-33.
49. Cassidy A, Brown JE, Hawdon A, Faughnan MS, King LJ, Millward J, et al. Factors affecting the bioavailability of soy isoflavones in humans after ingestion of physiologically relevant levels from different soy foods. J Nutr. 2006;136:45-51.
50. Brown NM, Wang J, Cotroneo MS, Zhao YX, Lamartiniere CA. Prepubertal genistein treatment modulates TGF-alpha, EGF and EGF-receptor mRNAs and proteins in the rat mammary gland. Mol Cell Endocrinol. 1998;144:149-65.
51. Warri A, Saarinen NM, Makela S, Hilakivi-Clarke L. The role of early life genistein exposures in modifying breast cancer risk. Br J Cancer. 2008;98:1485-93.
52. Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, et al. Soyfood intake during adolescence and subsequent risk of breast cancer. Cancer Epidemiol Biomarkers Prev. 2001;10:483-8.
53. Wu AH, Wan P, Hankin J, Tseng CC, Yu MC, Pike MC. Adolescent and adult soy intake and risk of breast cancer in Asian-Americans. Carcinogenesis. 2002;23:1491-6.
54. Korde LA, Wu AH, Fears T, Nomura AM, West DW, Kolonel LN, et al. Childhood soy intake and breast cancer risk in Asian American women. Cancer Epidemiol Biomarkers Prev. 2009;18:1050-9.
55. Thanos J, Cotterchio M, Boucher BA, Kreiger N, Thompson LU. Adolescent dietary phytoestrogen intake and breast cancer risk (Canada). Cancer Causes Control. 2006;17:1253-61.
56. Lee SA, Shu XO, Li H, Yang G, Cai H, Wen W, et al. Adolescent and adult soy food intake and breast cancer risk: results from the Shanghai Women's Health Study. Am J Clin Nutr. 2009;89:1920-6.
57. Trichopoulos D. Hypothesis: does breast cancer originate in utero? Lancet. 1990;335:939-40.
58. Park SK, Kang D, McGlynn KA, Garcia-Closas M, Kim Y, Yoo KY, et al. Intrauterine environments and breast cancer risk: meta-analysis and systematic review. Breast Cancer Res. 2008;10:R8.
59. Adlercreutz H, Yamada T, Wähälä K, Watanabe S. Maternal and neonatal phytoestrogens in Japanese women during birth. Am J Obstet Gynecol. 1999;180:737-43.
60. Setchell KD, Zimmer-Nechemias L, Cai J, Heubi JE. Exposure of infants to phytpestrogens from soy-based infant formula. Lancet. 1997;350:23-7.
61. Badger TM, Rosin MJ, Hakkak R, Rowlands JC, Korourian S. The health consequences of early soy consumption. J Nutr. 2002;132:559S-65S.
62. Huang WY, Winn DM, Brown LM, Gridley G, Bravo-Otero E, Diehl SR, et al. Hormone-related factors and risk of breast cancer in relation to estrogen receptor and progesterone receptor status. Am J Epidemiol. 2003;157:881-7.
63. Colditz GA, Rosner BA, Chen WY, Holmes MD, Hankinson SE. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004;96:218-28.
64. Dai Q, Shu XO, Jin F, Potter JD, Kushi LH, Teas J, et al. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer. 2001;85:372-8.
65. Linseisen J, Piller R, Hermann S, Chang-Claude J; German Case-Control Study. Dietary phytoestrogen intake and premenopausal breast cancer risk in a German case-control study. Int J Cancer. 2004;110:284-90.
66. Touillaud MS, Pillow PC, Jakovljevic J, Bondy ML, Singletary SE, Li D, et al. Effect of dietary intake of phytoestrogens on estrogen receptor status in premenopausal women with breast cancer. Nutr Cancer. 2005;51:162-9.
67. Suzuki T, Matsuo K, Tsunoda N, Hirose K, Hiraki A, Kawase T, et al. Effect of soybean on breast cancer according to receptor status: a case-control study in Japan. Int J Cancer. 2008;123:1674-80.
68. Wu AH, Koh WP, Wang R, Lee HP, Yu MC. Soy intake and breast cancer risk in Shingapore Chinese Health Study. Br J Cancer. 2008;99:196-200.
69. Li CI, Daling JR, Malone KE. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998. J Clin Oncol. 2003;21:28-34.
70. Lawson JS, Field AS, Champion S, Tran D, Ishikura H, Trichopoulos D. Low oestrogen receptor α expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet. 1999;354:1787-8.
71. Messina MJ. Legumes and soybeans: overview of their nutritional profiles and health effects. Am J Clin Nutr. 1999;70:439S-50S.
72. Hooper L, Ryder JJ, Kurzer MS, Lampe JW, Messina JM, Phipps WR, et al. Effects of soy protein and isoflavones on circulating hormone concentrations in pre- and post-menopausal women: a systematic review and meta-analysis. Hum Reprod Update. 2009;15:423-40.
73. Shimizu H, Ross RK, Bernstein L, Pike MC, Henderson BE. Serum oestrogen levels in postmenopausal women: comparison of American whites and Japanese in Japan. Br J Cancer. 1990;62:451-3.
74. Bernstein L, Yuan JM, Ross RK, Pike MC, Hanisch R, Lobo R, et al. Serum hormone levels in pre-menopausal Chinese women in Shanghai and white women in Los Angeles: results from two breast cancer case-control studies. Cancer Causes Control. 1990;1:51-8.
75. Ohta H, Komukai S, Sugimoto I, Fuyuki T, Makita K, Takamatsu K, et al. Effect of a HMG-CoA reductase inhibitor combined with hormone replacement therapy on lipid metabolism in Japanese women with hypoestrogenic lipidemia: a multicenter double-blind controlled prospective study. Maturitas. 1998;29:163-71.
76. Dowsett M, Donaldson K, Tsuboi M, Wong J, Yates R. Effects of the aromatase inhibitor anastrozole on serum oestrogens in Japanese and Caucasian women. Cancer Chemother Pharmacol. 2000;46:35-9.
77. Yoshimura N, Kasamatsu T, Sakata K, Hashimoto T, Cooper C. The relationship between endogenous estrogen, sex hormonebinding globulin, and bone loss in female residents of a rural Japanese community: the Taiji Study. J Bone Miner Metab. 2002;20:303-10.
78. Miyoshi Y, Tanji Y, Taguchi T, Tamaki Y, Noguchi S. Association of serum estrone levels with estrogen receptor-positive breast cancer risk in postmenopausal Japanese women. Clin Cancer Res. 2003;9:2229-33.
79. Nagata C, Nagao Y, Yamamoto S, Shibuya C, Kashiki Y, Shimizu H. Light exposure at night, urinary 6-sulfatoxymelatonin, and serum estrogens and androgens in postmenopausal Japanese women. Cancer Epidemiol Biomarkers Prev. 2008;17:1418-23.
80. Bosetti C, Spertini L, Parpinel M, Gnagnarella P, Lagiou P, Negri E, et al. Flavonoids and breast cancer risk in Italy. Cancer Epidemiol Biomarkers Prev. 2005;14:805-8.